January 26, 2018
9:00 am - 4:30 pm (Eastern Time)
Streamed live -- http://www.hhs.gov/live
U.S. Department of Health and Human Services
200 Independence Avenue, S.W.
Great Hall, H.H. Humphrey Building
Washington, DC 20201
Printer Friendly Version in PDF Format (1 PDF pages)
| 9:00 am - 9:15 am |
Welcome and Charge for Meeting Laura Gitlin, Chair |
|---|---|
| 9:15 am - 9:45 am |
Discussion on Progress Made Since Last Meeting Laura Gitlin and Rohini Khillan |
| 9:45 am - 11:00 am |
Discussion of the NAPA Council Driver Diagram Laura Gitlin, Rohini Khillan, and Bruce Finke |
| 11:00 am - 11:45 am |
Federal Workgroup Updates Erin Long, Shari Ling, and Richard Hodes |
| 11:45 am - 12:30 pm |
Public Comments |
| 12:30 pm - 1:30 pm |
LUNCH BREAK |
| 1:30 pm - 3:00 pm |
Research Subcommittee Agenda: The Journey from Targets to Treatments Bradley Hyman and Allan Levey, Council Members Eliezer Masliah and Laurie Ryan, NIA Eric Karran, Abbvie Cynthia Huling Hummel, Council Member, and Marion Weisse, Study Partner |
| 3:00 pm - 3:45 pm |
Dominantly Inherited Alzheimer Network (DIAN) Study Randy Bateman, Washington University School of Medicine |
| 3:45 pm - 4:30 pm |
Care Summit Report Laura Gitlin and Katie Maslow |
| 4:30 pm |
Adjourn |
January 26, 2018 -- Advisory Council Meeting #27
The meeting was held on Friday, January 26, 2018, in Washington, DC. The Research Subcommittee took charge of this meeting's theme, focusing on the process from targets to treatments. The Council heard speakers on the preclinical pipeline, the clinical trial pipeline, and the industry perspective. The meeting also included discussion of a driver diagram to guide the Council's future work, updates and a report from the October Care Summit, and federal workgroup updates. Material available from this meeting is listed below and at https://aspe.hhs.gov/advisory-council-alzheimers-research-care-and-services-meetings#Jan2018.
Comments and questions, or alerts to broken links, should be sent to napa@hhs.gov.
General Information
-
Agenda -- [HTML Version] [PDF Version]
-
Meeting Announcement -- [HTML Version] [PDF Version]
-
Meeting Summary -- [HTML Version] [PDF Version]
-
Public Comments -- [HTML Version]
Handouts
-
Care Summit Report Themes -- [PDF Version]
-
NAPA Driver Diagram Draft Examples -- [PDF Version]
-
Outline for Care Summit Final Report -- [PDF Version]
Presentation Slides
-
AbbVie's R&D Vision for Alzheimer's Disease -- [HTML Version] [PDF Version]
-
Care Summit Report -- [HTML Version] [PDF Version]
-
Clinical Subcommittee Update -- [HTML Version] [PDF Version]
-
Initiatives, Partnerships and Collaboration to Help Patients with the Highest Unmet Need: Dominantly Inherited Alzheimer's Disease Trials Unit (DIAN-TU) as a Case Example -- [HTML Version] [PDF Version]
-
Long-Term Services and Supports Committee Update -- [HTML Version] [PDF Version]
-
NAPA Driver Diagram -- [HTML Version] [PDF Version]
-
Overview of the Clinical Trial Pipeline for AD -- [HTML Version] [PDF Version]
-
Overview on NIA Preclinical Pipeline -- [HTML Version] [PDF Version]
-
Participating in an Alzheimer's Clinical Study: Perspectives on Involvement of a Person Living with Dementia and Her Study Partner -- [HTML Version] [PDF Version]
-
Progress Since October -- [HTML Version] [PDF Version]
-
Research Progress on Alzheimer's Disease and Related Dementias -- [HTML Version] [PDF Version]
-
Research Subcommittee Agenda: The Journey from Targets to Treatments -- [HTML Version] [PDF Version]